Congressman Tim Ryan Announces More than $8 Million in COVID-19 Funding for Ohio

Youngstown, OH – Congressman Tim Ryan (OH-13) today announced $7.3 million in funding from the Centers for Disease Control and Prevention (CDC) for the full State of Ohio and $894,035 in Department of Health and Human Services (HHS) funding to combat the coronavirus pandemic specifically in Northeast Ohio. The HHS funding was received through the Health Center Coronavirus Aid, Relief, and Economic Security (CARES) Act, and was awarded to Ohio North East Health Systems Inc. The CDC funding was awarded through the Coronavirus Preparedness and Response Supplemental Appropriations Act – in addition to the $15.6 million Ohio received previously for the COVID-19 response. 

“Northeast Ohio has been among the hardest hit in our state by the coronavirus outbreak. Access to resources like equipment and data management tools will be key to helping lift our community out of this crisis. This funding from CDC and HHS will help greatly. Though there is still much work to be done, I’m proud to announce funding that will help save lives and put us on the road to recovery,” said Congressman Ryan.

“Increasing the capacity of our nation’s public health infrastructure is critical to stopping the spread of COVID-19 in communities across this country,” said CDC Director Robert R. Redfield, M.D. “These funds will augment core public health capabilities including surveillance and predictive analytics, laboratory capacity, qualified frontline deployers, and the ability to rapidly respond to emerging disease clusters in communities that currently have limited person to person spread of the virus.”

The CDC funding will supplement an existing cooperative agreement to a number of states and local jurisdictions identified as having the highest number of reported COVID-19 cases and jurisdictions with accelerating COVID-19 cases. The CDC will award $186 million in additional funding to states, localities, and territories this week to support a range of activities such as lab equipment, supplies, staffing, shipping, infection control, surge staffing, monitoring of individuals, and data management. The funding will also supplement an existing cooperative agreement to state jurisdictions through the Emerging Infections Program (EIP) to enhance surveillance capabilities.

###